Davita Inc (NYSE:DVA) shares saw an uptick in trading volume on Wednesday . 6,255,718 shares were traded during mid-day trading, an increase of 313% from the previous session’s volume of 1,514,470 shares.The stock last traded at $76.08 and had previously closed at $69.25.
Several brokerages recently commented on DVA. Zacks Investment Research raised Davita from a “sell” rating to a “hold” rating in a research note on Tuesday, August 7th. ValuEngine lowered Davita from a “buy” rating to a “hold” rating in a research note on Wednesday, October 17th. Finally, JPMorgan Chase & Co. raised Davita from an “underweight” rating to a “neutral” rating in a research note on Thursday, September 13th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $82.50.
The company has a quick ratio of 1.88, a current ratio of 1.90 and a debt-to-equity ratio of 1.82. The stock has a market cap of $11.29 billion, a PE ratio of 22.92, a price-to-earnings-growth ratio of 0.87 and a beta of 1.09.
Davita (NYSE:DVA) last issued its quarterly earnings data on Wednesday, November 7th. The company reported $0.56 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($0.32). Davita had a net margin of 4.30% and a return on equity of 14.49%. The business had revenue of $2.85 billion during the quarter, compared to the consensus estimate of $2.93 billion. During the same quarter in the previous year, the firm posted $0.81 EPS. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. As a group, equities analysts expect that Davita Inc will post 4 earnings per share for the current year.
Institutional investors and hedge funds have recently modified their holdings of the business. United Asset Strategies Inc. raised its position in shares of Davita by 13.0% during the second quarter. United Asset Strategies Inc. now owns 6,405 shares of the company’s stock worth $445,000 after acquiring an additional 735 shares during the last quarter. Commonwealth Equity Services LLC raised its position in shares of Davita by 10.2% during the third quarter. Commonwealth Equity Services LLC now owns 8,168 shares of the company’s stock worth $585,000 after acquiring an additional 757 shares during the last quarter. Janney Montgomery Scott LLC raised its position in shares of Davita by 4.5% during the second quarter. Janney Montgomery Scott LLC now owns 19,009 shares of the company’s stock worth $1,320,000 after acquiring an additional 811 shares during the last quarter. Northstar Group Inc. raised its position in shares of Davita by 7.8% during the third quarter. Northstar Group Inc. now owns 11,684 shares of the company’s stock worth $837,000 after acquiring an additional 850 shares during the last quarter. Finally, Vident Investment Advisory LLC raised its position in shares of Davita by 1.5% during the second quarter. Vident Investment Advisory LLC now owns 57,294 shares of the company’s stock worth $3,979,000 after acquiring an additional 872 shares during the last quarter. Hedge funds and other institutional investors own 87.36% of the company’s stock.
WARNING: “Davita (DVA) Sees Strong Trading Volume” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another domain, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/11/07/davita-dva-sees-strong-trading-volume.html.
About Davita (NYSE:DVA)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Story: What is the NASDAQ?
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.